Back to Search Start Over

Findings from Texas State University Provides New Data about Neuroblastomas (Discovery of 5-sulfonyltetrazoles As Neuroblastoma Differentiation Agents).

Source :
Clinical Oncology Week; 11/21/2023, p399-399, 1p
Publication Year :
2023

Abstract

Researchers at Texas State University have discovered new data about neuroblastomas, a type of cancer. They developed a screening approach to measure neuroblastoma cell differentiation based on neurite outgrowth. Through their research, they identified a compound called 1-methyl-5-(ethylsulfonyl)-1H-tetrazole (3a) as a potential neuroblastoma differentiation agent. They also found that a related compound, 5-(allylsulfonyl)-1-methyl-1H-tetrazole (3c), had even stronger differentiation and cytotoxic activities. This research has been peer-reviewed and provides valuable insights into potential treatments for neuroblastomas. [Extracted from the article]

Details

Language :
English
ISSN :
15436799
Database :
Complementary Index
Journal :
Clinical Oncology Week
Publication Type :
Periodical
Accession number :
173665933